[Clinical effectiveness of clorazepate dipotassium (Tranxilium 20), used in a single daily dose, in neurotic disorders].
D000328:Adult; D014151:Anti-Anxiety Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003009:Clorazepate Dipotassium / Q000008:administration & dosage*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*; D010919:Placebos
D014151:Anti-Anxiety Agents; D010919:Placebos; D003009:Clorazepate Dipotassium
Ocena skuteczności klinicznej soli dwupotasowej chlorazepatu (Tranxilium 20), stosowanego w jednorazowej dawce dobowej, w zaburzeniach nerwicowych.